Tobacco and Vapes Bill

Jenny Riddell-Carpenter Excerpts

Report stage
Wednesday 26th March 2025 Commons Chamber

[Wera Hobhouse (Bath) (LD)]

I rise to speak to new clause 1 in my name. It would strengthen the Bill by requiring the Secretary of State to conduct a review and publish a report on the impact of contaminated e-liquid and ways to reduce its prevalence. It would also give the Secretary of State power to make regulations to kerb the harm caused by contaminated e-liquid.

I have been campaigning on the issue of Spice-spiked vapes ever since it came to my attention last summer. The Bill is an opportunity to make a real change on this hugely concerning problem that is sweeping through schools across the country. New clause 1 would improve our understanding of contaminated e-liquid and ensure that the necessary regulations could be introduced to reduce the harm that it causes. The issue was first uncovered by Professor Chris Pudney at the University of Bath, who found that one in six vapes confiscated in schools contained the synthetic drug Spice.

Spice is a dangerous prison drug that causes serious harm to users, including hallucinations, dizziness, chest pain, breathing difficulties and damage to vital organs. The highly addictive nature of Spice makes it a gateway to criminal activity, coercion and abuse. It is tragic that anyone would take this drug, but it is especially tragic when young people do, who are often unaware of the dangers. Many young people inadvertently smoke Spice under the impression that it is cannabis. Worryingly, recent investigations have found that vapes are being contaminated with not just Spice but ketamine and MDMA, which are particularly harmful when taken in high doses. The landscape of contaminated e-liquids is evolving rapidly, and it is likely that this issue will worsen if the Bill passes unamended.

An unintended consequence of banning disposable vapes is that it will drive more users towards refillable vapes, which are the primary vehicles for contaminated e-liquids. Refillable vapes are more susceptible to being spiked with harmful substances than disposable vapes. This shift could exacerbate an already significant public health threat, making it even harder to control the spread of dangerous substances in the market. I welcome the ban on disposable vapes, but we must take action to safeguard against these unintended consequences.

The Metropolitan police have warned about children accessing illicit vapes through social media platforms such as Snapchat and Telegram. There is clearly a link between social media-driven drug dealing and the rise of vaping in schools. The ease of access to vapes and their widespread use makes them even more difficult to regulate, and makes it difficult to protect individuals from unknowingly consuming illicit substances. There is a lack of knowledge and oversight, and counterfeit or illicit vape products are slipping through the cracks, exacerbating the already alarming rise in drug-related incidents. There is much more to understand about how illicit vapes and e-liquids are obtained. New clause 1 would set us on our way; it would ensure that we built on the research of Professor Pudney at the University of Bath by conducting a review of the impact and prevalence of these illicit e-liquids.

I have had several conversations with Ministers about this issue. First, in response to my Adjournment debate, the Minister for Policing, Fire and Crime Prevention committed to addressing the issue through the Bill. I also met the former public health Minister, who assured me that the Government and health officials were taking the issue very seriously. I appreciate that Ministers want to make changes in this area; I urge them please to follow through and make this change by supporting new clause 1.

As I have a little time, I note new clause 19, in the name of the right hon. Member for Melton and Syston (Edward Argar), which would require the Government to report on the availability of illegal tobacco and vaping products. This is a serious problem to which attention is rightfully being brought. I support that addition to the Bill, but the new clause does not quite get to the heart of the issue that I am focusing on. New clause 1 calls for a specific review of contaminated e-liquid and ways to reduce its prevalence, and gives the Secretary of State power to make regulations to combat the harm that contaminated e-liquid causes.

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

I welcome the amendments to the Bill. This is now a strengthened piece of legislation that will create the first smokefree generation. The chronic health issues that stem from smoking and their impact on our NHS are well known. The Bill, the amendments and what they will go on to achieve will be critical in supporting the NHS and improving health outcomes.

Smoking costs the economy and wider society more than £20 billion a year, including a cost of £3 billion to the NHS and social care. That is equivalent to the annual salary of almost 700,000 nurses or 500,000 GPs, and is the cost of more than 500 million GP appointments.

While the Bill will create the first smokefree generation, the Government recognise that we need to do more to help people quit smoking. That is why I was so glad to welcome the additional funding announced in December to support local authority-led stop smoking services. Suffolk was allocated an additional £900,000 for this year, which means that people in Suffolk Coastal will be able to access support and live healthier, smokefree lives. I know from personal experience just how hard that is. On the very day of the Bill’s Second Reading in November, I gave up smoking, because I had just voted on a Bill that would mean that my nieces and nephews would never legally be able to smoke. I have tried to give up smoking before—the last time was just before the general election, when in truth I never stood a chance of succeeding—but I was able to succeed this time only because I have moved to vapes. To quote something that has already been said, “If you smoke, vape; if you don’t smoke, don’t vape.” It is simple and true.

I spoke on Second Reading about the important role that the Bill will play in preventing young people from taking up vaping. The dramatic rise in children taking up vaping should be nationally recognised as one of the most concerning crises facing young people and children. The Bill will make it harder for young people to be drawn into vaping and will bring the law on vape advertising in line with that for tobacco advertising: there will be a total ban on vape advertising and sponsorship. There will also be a consultation on the vape flavours that we all know are far too appealing to children.

However, we need to do more. As I stand here delivering this contribution, new products are appearing on the market that seek to exploit the loopholes in the upcoming ban on single-use vapes. I understand that the Bill explicitly gives the Secretary of State power to regulate further to limit the size of vapes, and to ban the so-called big puff vapes, which provide more than 600 puffs per pod. Since Second Reading, we have seen products come on to the market that allow people to attach refillable 10 ml pods, creating, in effect, a 3,000-puff vape. That is not a big puff vape; it is a colossal puff vape.

[Wera Hobhouse]

The hon. Lady is talking about refillable vapes. Does she agree that contaminated refills are a huge problem, and that the Government should take that seriously and amend the Bill further?

[Jenny Riddell-Carpenter]

I thank the hon. Lady for her intervention. We have heard that point made articulately, and not just by her. I look forward to the Minister’s response to that.

The issue of the 3,000-puff vape and the additions that can be made to vapes are why I tabled new clause 21, which builds on themes that have been spoken about in the Chamber this afternoon. I welcome the power in the Bill for the Secretary of State to regulate further to standardise the size of reusable vapes, but my new clause would allow us to limit their size sooner and prevent rogue vape manufacturers from circumventing the rules while the Secretary of State undertakes further consultation on such measures. Though the Bill provides the power to standardise vapes, I am asking the Government to legislate now to standardise and regulate puffs per vape, so that we do not see an explosion of new vapes in the marketplace that are trying to get around the single-use vapes ban in this legislation.

I close by thanking the Minister and the Department for their work in bringing the Bill forward, and for the cross-departmental push to make vaping safer and reduce its appeal to children. I hope that it is welcomed in all parts of the House.

[Mrs Sureena Brackenridge (Wolverhampton North East) (Lab)]

I will focus my comments on the vaping elements of the Bill, and particularly the impact on children.

It is a desperately sad and damning reflection on our society that we now need a dedicated clinic at Alder Hey children’s hospital to treat children as young as 11 for vaping addiction. I was horrified to read Professor Isba’s account of children reaching for their vapes early in the morning, before they get out of bed. Their vape sits next to their mobile phone on the bedside table. The alarming rise in nicotine dependency among children is deeply troubling. Although I welcome the fact that the clinic’s success will lead to similar schemes being rolled out across the country, that is not a sign of progress; it is a glaring wake-up call.

Today, we have a chance, through the Bill, to break the cycle of addiction, protect our children and build a healthier future for country. We face the alarming rise of vaping, which has hooked a record number of young people. As a former deputy headteacher, I saw vaping spread through schools like wildfire. I caught students hiding vapes—already hooked before they even understood what addiction meant. I saw students who should have been focused on their schoolwork struggling instead with cravings that they could not control. I saw teachers battling to keep their students in the classroom, instead of sneaking puffs in the toilet. I spoke to worried parents who felt helpless and never thought that their child would be caught up in this. Vaping is not just a bad habit; it is a trap, and too many of our young people are already caught in it.

The situation that we face did not come about overnight. For far too long, the previous Government failed to act while vaping rates among children soared. It felt like the stable door was left wide open and the horse had bolted. We could sit back and do nothing, and watch another generation of young people in Wolverhampton North East and across the country get hooked, but that is not what a responsible Government do, and it is not what this Labour Government will do. Through the Bill, we will take bold action. Smokefree zones will be expanded to protect children, families and the most vulnerable in our communities. For those who want to quit, there will be real support, backed by real investment, delivering real results. For too long, we have seen a market designed to hook kids on nicotine, with bright colours, fruity flavours and shameless advertising that deliberately targets young people.

Oral Answers to Questions

Jenny Riddell-Carpenter Excerpts

Tuesday 25th March 2025 Commons Chamber

[Wes Streeting]

Despite the significant uplift announced by the Chancellor at the Budget, system financial returns during the planning round suggested an overspend for the coming year of between £5 billion to £6 billion. When I said I would not tolerate overspending in the NHS, I meant it. When I said I would go after unnecessary administrative costs, duplication and bureaucracy, I meant it. That is what this Government are doing to protect frontline services.

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

In Saxmundham in my constituency, Dr Havard has led a campaign for 20 years to transform the healthcare centre into a one-stop community healthcare hub. His practice has already expanded services, transforming health locally. Does the Minister agree that the Saxmundham healthcare hub is an excellent example and model for what this Government are trying to do to transform community healthcare?

[Stephen Kinnock]

My hon. Friend is absolutely right that shifting care from hospitals to the community is at the heart of our 10-year plan. I would be happy to meet the doctors leading this pilot to find out more about the excellent work that she describes.

Rare Cancers Bill

Jenny Riddell-Carpenter Excerpts

2nd reading
Friday 14th March 2025 Commons Chamber

[Dr Arthur]

Absolutely. Last week, I attended a reception for the Eve Appeal. I was really struck by the fact that early diagnosis was a big feature of what the charity was talking about, and I will come on to that in just a second.

As a consequence of the lack of recognition of the symptoms of rare cancers, too many people are diagnosed too late. Last week, at an event hosted by the Brain Tumour Charity, I met Gabrielle and her wife and children. Gabrielle told me how the neurologist to whom she was initially referred did not recognise her brain tumour symptoms, and told her instead to go home, breathe into a paper bag and get some counselling. If only curing brain tumours was so easy. Reflecting on the comment made by my hon. Friend the Member for South Shields (Mrs Lewell-Buck), an observation that I have made on this journey is that so many of the people who have talked about late diagnosis have been women. That is purely anecdotal, but it seems to be the case. When I was at the Eve Appeal reception, the point was made that so many women are turned away; the GP tells them that they are hormonal, premenstrual or premenopausal.

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

My hon. Friend is making an incredibly important point, with which many across the Chamber will agree. The statistics are particularly stark for women from black, Asian and minority ethnic backgrounds; they are even more likely to be dismissed.

[Dr Arthur]

I thank my hon. Friend and office neighbour for making that point, which was also made by Eve Appeal. I cannot remember the statistics, but there is a stark difference. I talked about this issue when I met the Minister yesterday and she gently pointed out to me that it is not just in healthcare where women are dismissed as hormonal, premenstrual and so on. I thanked her for reminding me of that in the gentlest possible way.

It is a cruel irony that rare cancers such as Gabrielle’s tumour are typically less survivable, making early diagnosis even more important. Rare cancer patients require early, not later, diagnosis. I have spoken about poor outcomes, lack of progress in developing treatments and late diagnosis. My Bill focuses on the first two points, but I want to acknowledge the need to improve diagnosis, because of comments that have already been made. I am sure that will feature in the cancer plan.

I am the first to admit that, when I was successful in the private Member’s Bill ballot, I found it daunting as a new MP. I thought I had some really good ideas for a Bill, but as soon as my ping-pong ball was picked from the goldfish bowl, I was inundated with calls from constituents, charities and lobbyists, each telling me that their cause was better than any I could think of. I considered many worthwhile causes over the following days, but while having a coffee in Colinton Mains Tesco in Edinburgh South West, I received emails from members of the public who support the campaign of my hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh). Just last week I met Oriana, one of the people who emailed me. It was incredibly moving to meet her; it took me right back to the start of this journey. I posted on my Facebook page about meeting her, and straight away somebody said that they knew her and that she had helped them when their family had been faced with glioblastoma. That is a reminder that so many people affected by these conditions turn their loss into something really positive and help other people.

My hon. Friend’s campaign relates to glioblastoma, a type of tumour that took my father-in-law. I felt that the stars had aligned for me. I really do mean that; I really did get that feeling. I want to pay tribute to my hon. Friend. [Hon. Members: “Hear, hear.”] More, more! I know her to be a formidable woman who in this context is driven by glioblastoma taking her sister, Margaret. I did not know her sister at all, which is my loss, but I do know that she shaped my party and she helped change our country for the better, and I know above all that she was loved by her sister.

Glioblastoma is typical of so many rare cancers, and it started me on this journey so I want to talk about it further. My father-in-law, Ivor Hutchison, was a dignified man but glioblastoma did not respect that. He was a technical teacher at Bell Baxter high school in Fife. He was married to Sylvia and they have four daughters, Denise, Iona, my lovely wife Audrey who is in the Gallery —I have just embarrassed her—and Sarah. In time, Ivor and Sylvia had grandchildren: Andrew, our daughter Ruth, Hannah, Matthew, our son Ben, Rory and Sophie. Ivor was not a passive grandfather; he worked hard to ensure his grandchildren flourished.

In September 2017, Ivor began having problems with his speech. My wife Audrey, an NHS nurse, was concerned that it might be a sign of dementia. We all hoped that that was not the case. Following an MRI scan in the November, we received the devastating news that Ivor had glioblastoma. At Christmas he was still very much himself and enjoyed the festivities. Ivor never had a pound of fat on him, but when it came to Christmas time he really did hoover up the food and enjoyed the Christmas meal. It was great to see him that Christmas, but we did feel that it would be his last. Once we entered the new year, he began to lose his mobility, and eventually he was admitted to Adamson hospital in Cupar. In 2018, surrounded by his wife and daughters, Ivor died peacefully, eight months after his first symptoms. He had a good life and his daughters are a fantastic legacy to him, as well as all the pupils he taught at school.

However, as a physically fit man, Ivor should have lived longer: he should have lived to see his birthday last weekend, and if he had done so, he would not have missed two of his grandchildren getting married and his first great-grandchild, Fraya, being born in December last year. I assumed that he had been unlucky with glioblastoma. It was not until I met my hon. Friend the Member for Mitcham and Morden that I learned that only 25% of glioblastoma patients live beyond 12 months after diagnosis, and only one in 20 survive beyond five years. Despite that awful prognosis, as for other rare cancers, the drugs to treat glioblastoma have not changed in decades. That is why I knew in my heart that I needed to introduce a Bill that would help equip those working hard to fight against glioblastoma, and all rare cancers, with the tools they need to further their efforts and, ultimately, save lives.

Over the past 15 years, thanks to the dedicated work of charities, survivors and researchers, we have seen a 10% rise in survival rates for those diagnosed with cancer. Globally, new treatments are being developed and rolled out to patients, improving outcomes and saving lives in our NHS every single day. However, rare cancer patients are being left behind, and I need to explain why. It is not due to a lack of effort by charities or those affected by the disease. In fact, in the Gallery today are members of some incredible charities who are fighting against rare cancers in what is often an uphill battle. I thank them for their hard work in helping me to develop the Bill—they really have helped me—which aims to address the injustices faced by rare cancer patients and their families. For all the people I have met from the charities, their work is much more than a job for them; it is about making a difference to people’s lives, improving survivability and supporting families.

The reason for the uphill battle is that research into rare cancer is much less appealing to pharmaceutical companies when compared with more common conditions. With smaller patient populations, there is an increased logistical challenge in bringing patients together. Currently, we are lacking a sufficient development strategy and there is no single source of patient data, meaning companies must undertake the costly endeavour of finding patients and verifying eligibility. Even if they succeed in running a clinical trial and a drug proves to be an effective treatment, companies face the challenge of selling a drug developed at great expense to a small market. Ultimately, these companies exist to return a profit for their shareholders. Given a choice between investment in potential treatment for a rare cancer or a more a common one, too often rare cancer patients lose out.

Having set out the challenges faced by those diagnosed with rare cancers, let me now address what the Bill aims to accomplish. I will list four key measures and explain their impact: appointing a named responsible lead for the delivery of rare cancer research; creating a single registry of rare cancer trials; creating a single registry of rare cancer patients available for trials; and defining an evidence base for repurposing new cancer treatments. Let me explain in turn why these are important.

First, the Bill would place a duty on the Secretary of State to facilitate and promote research related to rare cancer patients. The appointment of a national specialty lead for rare cancers in the National Institute of Health and Care Research would provide the Secretary of State with advice on the design and planning of research to facilitate collaboration between relevant parties. That will ensure co-ordination and accountability for the delivery of new cancer research in the UK.

Secondly, the Bill would increase access to clinical trials via a service tailored to rare cancer patients. Through the Secretary of State’s new duties, that would be accomplished as part of the existing “Be Part of Research” registry, ensuring that all trials are registered in a single place.

Thirdly, charities and clinicians tell me that more trials would be attracted to the UK if we had easier access to patient cohorts. Establishing a single database of willing patients would remove a significant burden on researchers in finding and verifying eligible people for clinical trials.

--- Later in debate ---

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

I start by thanking my hon. Friend the Member for Edinburgh South West (Dr Arthur) for bringing forward this important Bill. I thank the many other Members from across the House who have contributed so movingly today, and my constituents who reached out to me to share their views. I will try to keep my contribution brief, because I know others will want to speak.

In particular, I would like to thank Maria and her daughter Lauren, who told me about Maria’s journey and her fight against leiomyosarcoma—I am the second person today to struggle to pronounce that word—and how that diagnosis, during the covid lockdowns, turned her life upside down. Navigating the pandemic was hard enough; navigating it while one of the people you love most in the world is suffering with cancer must have been nearly impossible.

Maria is still living with leiomyosarcoma and has chemotherapy once a month. As she and her daughter told me, living with cancer is tough enough; when it is a rare cancer, patients live with the fear that the disease will act quicker than the research makes progress. That is why this Bill is so important. We need to close the gap in the treatment so that more people diagnosed with rare cancers have the same chance of survival as those with other cancers.

Another constituent of mine knows the cost of that all too well. He has asked me not to share his or his wife’s name, but instead to tell her story. She passed away last year after being diagnosed with leiomyosarcoma. Despite the best efforts of the oncology unit, the rarity of the cancer meant that it took too long to identify her condition. A year of chemotherapy followed, sadly to no avail.

Although I have two examples of leiomyosarcoma in my constituency, it is incredibly rare. One challenge of that cancer is its genetic variability and the fact that it has many different subtypes. Personalised medicine is particularly important for rare cancers with different subtypes, but because of the small number of patients with leiomyosarcoma, it is extremely difficult, if not impossible, to run robust clinical trials. Research is possible, however, and great strides are being made in the US, showing that better treatment and outcomes are possible. It is vital that we incentivise research of and investment into the treatment of rare cancers and begin to close that gap.

I thank my hon. Friend again for introducing this important debate and the Bill.

Tobacco and Vapes Bill

Jenny Riddell-Carpenter Excerpts

2nd reading
Tuesday 26th November 2024 Commons Chamber

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

I start by welcoming this Bill, which will create the first smokefree generation. Children turning 15 this year will never legally be able to be sold tobacco.

As we look to reform and transform our NHS and improve health outcomes for our country, we cannot do so without tackling the root causes. The long-term chronic health issues that stem from smoking and the impact that they have on our NHS are well known and have been well covered today; they do not need rehearsing by me. It is worth noting that fewer young people take up smoking each year, which is good news and should be welcomed by Members. The proportion of adults aged 16 and over in the UK who said that they smoked cigarettes decreased significantly from 12.7% in 2021 to 11.2% in 2022, continuing the downwards trend seen since 1974. Recent research by Go Smoke Free shows from analysis of Office for National Statistics figures that between 2015 and 2023 the percentage of adults who smoke in Suffolk has declined to 10.6%, down from 16% in 2016.

That positive downwards trend does not mean that young people are safe from the addictions of smoking or that further interventions by this Government are not needed. Alongside the decrease in young people taking up smoking and the decline in adults in Suffolk smoking, we have seen an increase in young people and children taking up vaping. The vaping epidemic among children and young people should be a great concern to us all on both sides of this Chamber. In 2023, 20% of children had tried vaping, which was almost double the figure in 2020, before the first covid lockdown. This rapid trajectory is frightening, and I share the concerns of many parents who have written to me about the availability of vapes and the marketing of them, which so often seems as if it is targeted directly at children.

We know that disposable vapes are the products of choice for the majority of children vaping today, and I therefore welcome the ban on disposable vapes that this Bill will bring forward. The new legislation will not only protect the environment, but help to make huge strides in reducing the appeal of vapes to young people and help to keep them out of the hands of the most vulnerable children. I also welcome the Bill’s drive to ban the advertising and sponsorship of vapes and nicotine products and allow regulation of the flavours, packaging and display of vapes so that they cannot be marketed to appeal to children. It is astonishing that it is currently legal for vapes to be sold from locations such as the back of taxis, toy stores and confectioners. This practice must stop, and I am glad that the Bill seeks to tackle that—in particular, it will be hugely welcome to constituents in Suffolk Coastal.

In my constituency, we have vape shops clearly targeting children and young people and advertising products along with sweets in a clear attempt to market and sell them to those aged under 18. Residents in Felixstowe have been rightly outraged by the recent opening of an American sweet and vape store right on the high street in a prime location that is so clearly targeting children. I hope that under the terms of the Bill, stores such as that will be in breach of the law. I will follow the detail closely. I am also reassured that the £200 fixed penalty notice will enable trading standards officers to act on the spot to clamp down on under-age sales.

This Bill is welcome, and it should be welcomed by Members on both sides of the House. I look forward to voting in favour of it later, and I will do so on behalf of the residents of my constituency who have expressed their direct concerns to me.

[Several hon. Members rose—]

Oral Answers to Questions

Jenny Riddell-Carpenter Excerpts

Tuesday 15th October 2024 Commons Chamber

[Stephen Kinnock]

It beggars belief that Opposition Members should lecture us on fiscal discipline when there is a £22 billion in-year black hole. We are committed to consulting widely on the design of a fair pay agreement, and we will engage with all who may be affected. We are keen to ensure that all voices are heard so that the financial impacts on the adult social care market, local government and self-funders can be considered, but in a week in which this Government have attracted £63 billion of investment and just days after the publication of the Employment Rights Bill, we are seeing a Government who are pro-business, pro-worker and pro-growth.

[Jenny Riddell-Carpenter (Suffolk Coastal) (Lab)]

Adult social care is under extreme pressure. One in four hospital beds are occupied by patients with dementia. Will the Minister commit himself to the delivery of a dementia strategy in the current Parliament?

[Stephen Kinnock]

That is an extremely important question. I recognise that dementia is a huge issue that impacts on the entire country and, indeed, many Members on both sides of the House. We are absolutely committed to the research that is fundamental to addressing the problem, and our fair pay agreement is about not just pay but training and terms and conditions. We will be ramping up dementia training for our adult social care workforce.